We are live on ! Find out more
AA

ALPS Advisors Portfolio holdings

AUM $21.3B
1-Year Est. Return 21.71%
This Fund
S&P 500
This Quarter Est. Return
+2.38%
1 Year Est. Return
+21.71%
3 Year Est. Return
+77.63%
5 Year Est. Return
+121.1%
10 Year Est. Return
+198.29%
AUM
$15.8B
AUM Growth
+$903M
Cap. Flow
+$681M
Cap. Flow %
4.3%
Top 10 Hldgs %
59.4%
Holding
1,049
New
56
Increased
385
Reduced
332
Closed
59

Top Buys

Rank Stock Value
1
HESM icon
Hess Midstream
HESM
+$133M
2
WES icon
Western Midstream Partners
WES
+$118M
3
PAA icon
Plains All American Pipeline
PAA
+$107M
4
SUN icon
Sunoco
SUN
+$77.7M
5
ENLC
ENLINK MIDSTREAM, LLC
ENLC
+$44.6M

Top Sells

Rank Stock Value
1
ET icon
Energy Transfer Partners
ET
+$60.2M
2
CMI icon
Cummins
CMI
+$28M
3
WMB icon
Williams Companies
WMB
+$27.6M
4
GILD icon
Gilead Sciences
GILD
+$26.2M
5
HD icon
Home Depot
HD
+$26M

Sector Composition

Rank Sector Weight
1 Energy 68.68%
2 Technology 4.5%
3 Financials 3.53%
4 Consumer Discretionary 3.3%
5 Healthcare 2.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SIGA icon
951
SIGA Technologies
SIGA
$223M
$266K ﹤0.01%
44,250
-500
-1% -$3.34K
TDW icon
952
Tidewater
TDW
$3.91B
$265K ﹤0.01%
4,850
– –
DHI icon
953
D.R. Horton
DHI
$41B
$256K ﹤0.01%
1,834
– –
SLRN
954
DELISTED
ACELYRIN
SLRN
$255K ﹤0.01%
81,129
+3,883
+5% +$18.8K
INSW icon
955
International Seaways
INSW
$4.57B
$254K ﹤0.01%
7,075
– –
GRBK icon
956
Green Brick Partners
GRBK
$3.13B
$253K ﹤0.01%
4,473
– –
SDHC icon
957
Smith Douglas Homes
SDHC
$127M
$250K ﹤0.01%
9,750
-200
-2% -$6.65K
ALDX icon
958
Aldeyra Therapeutics
ALDX
$91.7M
$240K ﹤0.01%
48,155
+2,619
+6% +$13.4K
ASC icon
959
Ardmore Shipping
ASC
$678M
$240K ﹤0.01%
19,750
-500
-2% -$6.79K
RIGL icon
960
Rigel Pharmaceuticals
RIGL
$680M
$240K ﹤0.01%
+14,240
New +$273K
MPWR icon
961
Monolithic Power Systems
MPWR
$65.5B
$234K ﹤0.01%
396
– –
DFH icon
962
Dream Finders Homes
DFH
$1.46B
$234K ﹤0.01%
10,064
-200
-2% -$6.11K
RZLT icon
963
Rezolute
RZLT
$480M
$230K ﹤0.01%
+46,850
New +$236K
ITOS
964
DELISTED
iTeos Therapeutics
ITOS
$227K ﹤0.01%
29,540
+3,065
+12% +$26.3K
SLI
965
Standard Lithium
SLI
$517M
$227K ﹤0.01%
155,337
+61,283
+65% +$113K
VNDA icon
966
Vanda Pharmaceuticals
VNDA
$312M
$226K ﹤0.01%
47,149
+3,113
+7% +$14.9K
REGN icon
967
Regeneron Pharmaceuticals
REGN
$68.8B
$221K ﹤0.01%
310
– –
PLD icon
968
Prologis
PLD
$138B
$215K ﹤0.01%
2,034
-160
-7% -$18.4K
AMLX icon
969
Amylyx Pharmaceuticals
AMLX
$2.05B
$210K ﹤0.01%
+55,430
New +$261K
CMPS
970
Compass Pathways
CMPS
$1.52B
$209K ﹤0.01%
55,332
+2,927
+6% +$14.8K
FDMT icon
971
4D Molecular Therapeutics
FDMT
$526M
$208K ﹤0.01%
37,379
-1,964
-5% -$15.4K
LRMR icon
972
Larimar Therapeutics
LRMR
$416M
$200K ﹤0.01%
+51,590
New +$341K
ELDN icon
973
Eledon Pharmaceuticals
ELDN
$276M
$199K ﹤0.01%
+48,310
New +$190K
PROK icon
974
ProKidney
PROK
$308M
$175K ﹤0.01%
103,477
+6,081
+6% +$11K
ZNTL icon
975
Zentalis Pharmaceuticals
ZNTL
$308M
$174K ﹤0.01%
57,587
+1,371
+2% +$4.49K
37 38
39
40 41

Similar funds

PAG
Private Advisor Group Morristown, New Jersey $21.3B AUM 22.13% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return
IC
IEQ Capital Foster City, California $21.5B AUM 75.26% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return
VARA
Value Aligned Research Advisors Princeton, New Jersey $20.7B AUM 292.88% 1-Year Est. Return
SC
Savant Capital Rockford, Illinois $20.7B AUM 19.76% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

ALPS Advisors's Q4 2024 Portfolio in Review

As of Q4 2024, ALPS Advisors held 1,049 positions worth $15.8B, up 6% from $14.9B the previous quarter. Its ten largest holdings account for 59% of the portfolio.

ALPS Advisors deployed $681M of net new capital in Q4 2024, opening 56 new positions and adding to 385 existing holdings. Its largest new stake was CVS Health: 490,700 shares worth $22M.

By sector, the portfolio is most concentrated in Energy at 69% of assets, up from 66% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Energy Transfer Partners, an estimated $60.2M trimmed.

  • ALPS Advisors's largest Q4 2024 buy was CVS Health: 490,700 shares worth $22M.
  • ALPS Advisors added most to Hess Midstream in Q4 2024, an estimated $133M increase.
  • ALPS Advisors's biggest Q4 2024 reduction was Energy Transfer Partners, cutting an estimated $60.2M.
  • ALPS Advisors fully exited Corning in Q4 2024, selling an estimated $25.6M.
  • ALPS Advisors's ten largest holdings make up 59% of its $15.8B portfolio in Q4 2024.
  • ALPS Advisors opened 56 new positions and closed 59 in Q4 2024.
  • ALPS Advisors's portfolio value rose 6% quarter-over-quarter to $15.8B.

Based on ALPS Advisors's 13F filing for Q4 2024, filed 13 Feb 2025.